AP1780A
Use of cox-2 inhibitors for preventing immunodeficiency.
Abstract
The present invention provides a method for treating or preventing a disorder typified by an immunodeficiency (e.g. HIV), wherein the patient is administered a COX-2 inhibitor or derivative or pharmaceutically acceptable salt thereof, preferably diisopropylfluophasphaate, L-745337, rofecoxi, NS 398, SC 58125, etodolac, meloxicam, celecoxib flusolide or nimesulide, and compositions and products containing the same or use of the same in preparing medicaments and for treatment.
Term
No projected expiry on record.
- Priority
- Filed
- Granted
- Today
Every citation, both ways
| Document | Relation | Office | Cited during |
|---|---|---|---|
| WO9729774A1 | Cites | World Intellectual Property Organization (WIPO) | Search report |
| WO9820864A2 | Cites | World Intellectual Property Organization (WIPO) | Search report |
91 members in 35 offices
Priority claims12
| Document | Office | Kind | Date |
|---|---|---|---|
| 0017908 | United Kingdom | A | |
| 0017908 | United Kingdom | A | |
| 0109648 | United Kingdom | A | |
| 0109648 | United Kingdom | A | |
| 0119147 | United States of America | W | |
| 0119147 | United States of America | W | |
| 00179085 | – | – | – |
| 01096486 | – | – | – |
| GB20000017908 | – | – | – |
| GB20010009648 | – | – | – |
| PCTGB0103284 | – | – | – |
| WO2001US19147 | – | – | – |
Members91
| Document | Office | Kind | |
|---|---|---|---|
| GB0017908D0 | United Kingdom | D0 | |
| GB0109648D0 | United Kingdom | D0 | |
| CA2413163A1 | Canada | A1 | |
| WO0196353A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU6692701A | Australia | A | |
| UY26779A1 | Uruguay | A1 | |
| CA2415577A1 | Canada | A1 | |
| WO0207721A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU7090201A | Australia | A | |
| PE20020216A1 | Peru | A1 | |
| WO0196353A3 | World Intellectual Property Organization (WIPO) | A3 | |
| WO0207721A3 | World Intellectual Property Organization (WIPO) | A3 | |
| NO20026001D0 | Norway | D0 | |
| NO20030276D0 | Norway | D0 | |
| NO20026001L | Norway | L | |
| NO20030276L | Norway | L | |
| AP2003002713A0 | African Regional Intellectual Property Organization (ARIPO) | A0 | |
| EP1296995A2 | European Patent Office (EPO) | A2 | |
| EP1303265A2 | European Patent Office (EPO) | A2 | |
| KR20030032967A | Republic of Korea | A | |
| US2003083306A1 | United States of America | A1 | |
| CZ2003122A3 | Czechia | A3 | |
| BR0111732A | Brazil | A | |
| AP2003002719A0 | African Regional Intellectual Property Organization (ARIPO) | A0 | |
| IL153379A0 | Israel | A0 | |
| IL153379D0 | Israel | D0 | |
| EA200300023A1 | Eurasian Patent Organization (EAPO) | A1 | |
| CN1452627A | China | A | |
| HU0302068A2 | Hungary | A2 | |
| HUP0302068A2 | Hungary | A2 | |
| HK1055087A | Hong Kong, China | A | |
| HK1055087A1 | Hong Kong, China | A1 | |
| NZ524252A | New Zealand | A | |
| JP2004510705A | Japan | A | |
| ZA200300446B | South Africa | B | |
| US2004082640A1 | United States of America | A1 | |
| AR035711A1 | Argentina | A1 | |
| ZA200300168B | South Africa | B | |
| PL359556A1 | Poland | A1 | |
| PL360404A1 | Poland | A1 | |
| MXPA02012443A | Mexico | A | |
| JP2004533403A | Japan | A | |
| MA27126A1 | Morocco | A1 | |
| CN1561204A | China | A | |
| NZ523632A | New Zealand | A | |
| US6875751B2 | United States of America | B2 | |
| US2005113330A1 | United States of America | A1 | |
| HU0302068A3 | Hungary | A3 | |
| HUP0302068A3 | Hungary | A3 | |
| ZA200404306B | South Africa | B | |
| EA005774B1 | Eurasian Patent Organization (EAPO) | B1 | |
| YU94802A | Yugoslavia, later Serbia and Montenegro (until 2006) | A | |
| OA12384A | African Intellectual Property Organization (OAPI) | A | |
| OA12339A | African Intellectual Property Organization (OAPI) | A | |
| NZ535246A | New Zealand | A | |
| AU2001266927B2 | Australia | B2 | |
| CN1295242C | China | C | |
| CN1900104A | China | A | |
| IL153379A | Israel | A | |
| IL178864A0 | Israel | A0 | |
| IL178864D0 | Israel | D0 | |
| AU2007201035A1 | Australia | A1 | |
| KR20070048277A | Republic of Korea | A | |
| AP2007003992A0 | African Regional Intellectual Property Organization (ARIPO) | A0 | |
| EP1303265B1 | European Patent Office (EPO) | B1 | |
| RU2303452C2 | Russian Federation | C2 | |
| CN101012259A | China | A | |
| AT366569T | Austria | T | |
| ATE366569T1 | Austria | T1 | |
| AP1771A | African Regional Intellectual Property Organization (ARIPO) | A | |
| DE60129330D1 | Germany | D1 | |
| AP1780AThis record | African Regional Intellectual Property Organization (ARIPO) | A | |
| PT1303265E | Portugal | E | |
| DK1303265T3 | Denmark | T3 | |
| ES2290157T3 | Spain | T3 | |
| DE60129330T2 | Germany | T2 | |
| AT411332T | Austria | T | |
| ATE411332T1 | Austria | T1 | |
| EP1296995B1 | European Patent Office (EPO) | B1 | |
| CA2413163C | Canada | C | |
| DE60136181D1 | Germany | D1 | |
| ES2317912T3 | Spain | T3 | |
| CN100488500C | China | C | |
| US7585851B2 | United States of America | B2 | |
| MY141594A | Malaysia | A | |
| US7790738B2 | United States of America | B2 | |
| CA2415577C | Canada | C | |
| JP4639032B2 | Japan | B2 | |
| NO330509B1 | Norway | B1 | |
| CZ302448B6 | Czechia | B6 | |
| CY1107069T1 | Cyprus | T1 |
Numbers
- Publication
- AP 1780
- Publication, DOCDB
- 1780
- Publication, EPODOC
- AP1780
- Application
- 2003002719
- Application, DOCDB
- 2003002719
- Application, EPODOC
- AP20030002719
Titles
- English
- Use of cox-2 inhibitors for preventing immunodeficiency.
Classification
- CPC, 14
- A61K31/6615
- A61K31/18
- A61K31/365
- A61K31/381
- A61K31/405
- A61K31/407
- A61K31/415
- A61K31/5415
- A61K31/675
- A61P29/00
- A61P31/12
- A61P31/18
- A61P37/02
- A61P43/00
- IPC, 18
- A61K45 00
- A61K31 18
- A61K31 341
- A61K31 365
- A61K31 381
- A61K31 385
- A61K31 405
- A61K31 407
- A61K31 415
- A61K31 5415
- A61K31 661
- A61K31 675
- A61K45 06
- A61P29 00
- A61P31 12
- A61P31 18
- A61P37 02
- A61P43 00